Connect with us

Hi, what are you looking for?

Expo-ETFExpo-ETF

Investing

First patient dosed in Phase IIb imaging for Brain Mets

Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets

Download the PDF here.

This post appeared first on investingnews.com

You May Also Like

Stock

On Monday, the Dow dropped over 1,000 points after President Trump’s new round of criticism directed at Fed Chair Jerome Powell. The selloff reflects...

Investing

(TheNewswire) Vancouver, British Columbia TheNewswire – April 23 rd, 2025 Juggernaut Exploration Ltd. (TSX-V: JUGR) (OTCQB: JUGRF) (FSE: 4JE) (the ‘Company’ or ‘Juggernaut’), further...

Editor's Pick

Tech billionaire Elon Musk said Tuesday that he will begin dedicating more time to Tesla and less to his work with the Trump administration...

Investing

Impacted by broad uncertainty, geopolitical risks and trade tensions, spot U308 prices fell 13.26 percent during Q1 2025, starting the session at US$74.74 per...

Disclaimer: Expo-ETF.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 Expo-ETF.com All Rights Reserved.